ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1192

Tumor Necrosis Factor-alpha Is Independently Associated with Anemia in Pediatric Patients with CKD

Session Information

Category: Pediatric Nephrology

  • 1800 Pediatric Nephrology

Authors

  • Munera, Ana Maria, Weill Cornell Medicine, New York, New York, United States
  • Zhu, Yuan-Shan, Weill Cornell Medicine, New York, New York, United States
  • Liu, Diane, Weill Cornell Medicine, New York, New York, United States
  • Akchurin, Oleh M., Weill Cornell Medicine, New York, New York, United States
Background

Anemia is a common complication of chronic kidney disease (CKD) involving impaired erythropoiesis and disordered iron handling, both linked to inflammation via effects on both erythropoietin responsiveness and iron availability. While interleukin (IL)-6 contributes via hepcidin-mediated iron restriction, other potentially targetable pathways remains incompletely understood. TNF-α is of interest given available anti-TNF therapies and evidence of effects on erythropoiesis in non-CKD inflammatory anemia, but its independent role in pediatric CKD has not been established.

Methods

We performed a cross-sectional analysis of a pediatric CKD cohort at Weill Cornell Medicine (CKD stages I-V non-dialysis). The exposure was log-transformed TNF-α (pg/mL); the outcome was hemoglobin (Hb, g/dL). Participants were grouped by TNF-α tertiles. Sequential multivariable linear regression evaluated the TNF-α-Hb association adjusting for: (M1) unadjusted; (M2) age, sex; (M3) + eGFR; (M4a-c) + serum iron, transferrin saturation (TSAT), or ferritin; (M5a-b) + log IL-6 or log IFN- γ. Mediation analysis used the Baron & Kenny approach with Sobel test.

Results

The cohort (N=98) had median age 11.4 years (60% male, 22% Black; mean Hb 12.3 g/dL). Across TNF-α tertiles (T1/T2/T3), Hb (12.9/ 12.8/ 11.1 g/dL, p<0.001) and serum iron (78.6/ 83.7/ 59.5 μg/dL, p=0.007) declined, ferritin increased nonsignificantly (p=0.27), suggesting functional iron deficiency. TNF-α correlated inversely with Hb (r=-0.38, p<0.001) and serum iron (r=-0.27, p=0.025) and positively with IFN- γ (r=0.56, p<0.01) and IL-6 (r=0.32, p=0.002). Log TNF-α remained associated with lower Hb through models M1-M3 (all p<0.001) and after adjustment for log-IL-6 (M5a, p=0.01), indicating non-redundant cytokine effects. Adjustment for serum iron (M4a, p=0.011) and TSAT (M4b, p=0.5) attenuated the association. Serum iron mediated 23% of the TNF-α effect on Hb (B=-19.3, p=0.02; Sobel p=0.04). Ferritin was not a mediator (p=0.55). Adjustment for IFN-γ further attenuated the association (M5b, p=0.07), supporting a shared inflammatory axis.

Conclusion

TNF-α is associated with anemia in pediatric CKD independent of kidney function, age and IL-6. Iron partly mediates this effect, implicating TNF-α-driven iron restriction, potentially alongside IFN-γ. TNF-α may represent a novel therapeutic target to correct anemia in children with CKD and inflammation.

Funding

  • NIDDK Support